Biogen (BIIB)
$159.8 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Biogen, AI stock picks, stock alerts and much more.
BIIB AI Stock Analysis
AI stock analysis for BIIB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biogen (BIIB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BIIB Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biogen (BIIB), currently trading at $159.8, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BIIB
-
Biogen Inc.
-
Symbol
BIIB
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
23.3B
Similar Stocks
 |
Astrazeneca AZN |
$67.2 1.3% |
7 |
 |
Amgen AMGN |
$280.1 0% |
6 |
 |
Gilead Sciences GILD |
$92.41 1.2% |
6 |
 |
Sanofi SNY |
$48.72 0.9% |
6 |
News
BIIB Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
BIIB Financials
BIIB Key Metrics
-
Total Revenue
$2.5B
-
Net Income
$388.5M
-
Earnings per Share
$2.67
-
Free cash flow
$1.2B
-
EBITDA
$451M
-
EBITDA Ratio
0.182902
-
Total Assets
$28.3B
BIIB 2-year Revenue & Income
BIIB 2-year Free Cash Flow
BIIB Technicals
BIIB SMA
BIIB RSI
FAQ
What's the current price of Biogen (BIIB) Stock?
The price of an Biogen (BIIB) share is $159.8.
What's the market cap of Biogen?
The current market cap of Biogen is 23.3B.
Should I buy or sell BIIB?
Biogen shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Biogen is better viewed as a hold or accumulate position while waiting for further developments.
Is Biogen a good investment?
The current analysis of Biogen's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Biogen's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Biogen (BIIB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Biogen stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Biogen (BIIB) that investors often compare it to?
Biogen (BIIB) is often compared to similar stocks such as Astrazeneca, Amgen, Gilead Sciences and Sanofi.
What is the forecast for Biogen's stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biogen's stock price to be around $168 in 2025. Starting from the current price of $159.8, this represents a 5.1% change in price, indicating a bullish outlook for the stock.
How to buy Biogen (BIIB) Stock?
Biogen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biogen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.